Global Gastrointestinal Cancer Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Page: 112
Published Date: 06 Jan 2022
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Gastrointestinal Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gastrointestinal Cancer Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Gastrointestinal Cancer Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Surgery segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Gastrointestinal Cancer Treatment include Eli Lilly, F. Hoffmann, GlaxoSmithKline, Merck, and Novartis AG, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gastrointestinal Cancer Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy
Market segment by Application, can be divided into
Hospitals
Clinics
Research Centers
Others
Market segment by players, this report covers
Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gastrointestinal Cancer Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gastrointestinal Cancer Treatment, with revenue, gross margin and global market share of Gastrointestinal Cancer Treatment from 2019 to 2022.
Chapter 3, the Gastrointestinal Cancer Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gastrointestinal Cancer Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gastrointestinal Cancer Treatment research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Gastrointestinal Cancer Treatment
1.2 Classification of Gastrointestinal Cancer Treatment by Type
1.2.1 Overview: Global Gastrointestinal Cancer Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Type in 2021
1.2.3 Surgery
1.2.4 Targeted Drugs Therapy
1.2.5 Chemo Therapy
1.2.6 Adjuvant Chemotherapy
1.2.7 Radiation Therapy
1.3 Global Gastrointestinal Cancer Treatment Market by Application
1.3.1 Overview: Global Gastrointestinal Cancer Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Global Gastrointestinal Cancer Treatment Market Size & Forecast
1.5 Global Gastrointestinal Cancer Treatment Market Size and Forecast by Region
1.5.1 Global Gastrointestinal Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Gastrointestinal Cancer Treatment Market Size by Region, (2017-2022)
1.5.3 North America Gastrointestinal Cancer Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Gastrointestinal Cancer Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Gastrointestinal Cancer Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Gastrointestinal Cancer Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Gastrointestinal Cancer Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastrointestinal Cancer Treatment Market Drivers
1.6.2 Gastrointestinal Cancer Treatment Market Restraints
1.6.3 Gastrointestinal Cancer Treatment Trends Analysis
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Gastrointestinal Cancer Treatment Product and Solutions
2.1.4 Eli Lilly Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 F. Hoffmann
2.2.1 F. Hoffmann Details
2.2.2 F. Hoffmann Major Business
2.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Product and Solutions
2.2.4 F. Hoffmann Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 F. Hoffmann Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Product and Solutions
2.3.4 GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Gastrointestinal Cancer Treatment Product and Solutions
2.4.4 Merck Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck Recent Developments and Future Plans
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Gastrointestinal Cancer Treatment Product and Solutions
2.5.4 Novartis AG Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Novartis AG Recent Developments and Future Plans
2.6 Otsuka Holdings
2.6.1 Otsuka Holdings Details
2.6.2 Otsuka Holdings Major Business
2.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Product and Solutions
2.6.4 Otsuka Holdings Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Otsuka Holdings Recent Developments and Future Plans
2.7 Stryker Corporation
2.7.1 Stryker Corporation Details
2.7.2 Stryker Corporation Major Business
2.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Product and Solutions
2.7.4 Stryker Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Stryker Corporation Recent Developments and Future Plans
2.8 Boston Scientific Corporation
2.8.1 Boston Scientific Corporation Details
2.8.2 Boston Scientific Corporation Major Business
2.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Product and Solutions
2.8.4 Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Boston Scientific Corporation Recent Developments and Future Plans
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business
2.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Product and Solutions
2.9.4 Johnson and Johnson Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Johnson and Johnson Recent Developments and Future Plans
2.10 CONMED Corporation
2.10.1 CONMED Corporation Details
2.10.2 CONMED Corporation Major Business
2.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Product and Solutions
2.10.4 CONMED Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 CONMED Corporation Recent Developments and Future Plans
2.11 Bristol-Myers Squibb
2.11.1 Bristol-Myers Squibb Details
2.11.2 Bristol-Myers Squibb Major Business
2.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product and Solutions
2.11.4 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Gastrointestinal Cancer Treatment Product and Solutions
2.12.4 Pfizer Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Pfizer Recent Developments and Future Plans
2.13 Celltrion Inc
2.13.1 Celltrion Inc Details
2.13.2 Celltrion Inc Major Business
2.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Product and Solutions
2.13.4 Celltrion Inc Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Celltrion Inc Recent Developments and Future Plans
2.14 Amgen Limited
2.14.1 Amgen Limited Details
2.14.2 Amgen Limited Major Business
2.14.3 Amgen Limited Gastrointestinal Cancer Treatment Product and Solutions
2.14.4 Amgen Limited Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Amgen Limited Recent Developments and Future Plans
2.15 Celgene Corporation
2.15.1 Celgene Corporation Details
2.15.2 Celgene Corporation Major Business
2.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Product and Solutions
2.15.4 Celgene Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Celgene Corporation Recent Developments and Future Plans
2.16 Sanofi
2.16.1 Sanofi Details
2.16.2 Sanofi Major Business
2.16.3 Sanofi Gastrointestinal Cancer Treatment Product and Solutions
2.16.4 Sanofi Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Sanofi Recent Developments and Future Plans
3.1 Global Gastrointestinal Cancer Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Gastrointestinal Cancer Treatment Players Market Share in 2021
3.2.2 Top 10 Gastrointestinal Cancer Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Gastrointestinal Cancer Treatment Players Head Office, Products and Services Provided
3.4 Gastrointestinal Cancer Treatment Mergers & Acquisitions
3.5 Gastrointestinal Cancer Treatment New Entrants and Expansion Plans
4.1 Global Gastrointestinal Cancer Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Gastrointestinal Cancer Treatment Market Forecast by Type (2023-2028)
5.1 Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Gastrointestinal Cancer Treatment Market Forecast by Application (2023-2028)
6.1 North America Gastrointestinal Cancer Treatment Revenue by Type (2017-2028)
6.2 North America Gastrointestinal Cancer Treatment Revenue by Application (2017-2028)
6.3 North America Gastrointestinal Cancer Treatment Market Size by Country
6.3.1 North America Gastrointestinal Cancer Treatment Revenue by Country (2017-2028)
6.3.2 United States Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
7.1 Europe Gastrointestinal Cancer Treatment Revenue by Type (2017-2028)
7.2 Europe Gastrointestinal Cancer Treatment Revenue by Application (2017-2028)
7.3 Europe Gastrointestinal Cancer Treatment Market Size by Country
7.3.1 Europe Gastrointestinal Cancer Treatment Revenue by Country (2017-2028)
7.3.2 Germany Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
7.3.3 France Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
8.1 Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region
8.3.1 Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Region (2017-2028)
8.3.2 China Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
8.3.5 India Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
9.1 South America Gastrointestinal Cancer Treatment Revenue by Type (2017-2028)
9.2 South America Gastrointestinal Cancer Treatment Revenue by Application (2017-2028)
9.3 South America Gastrointestinal Cancer Treatment Market Size by Country
9.3.1 South America Gastrointestinal Cancer Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
10.1 Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country
10.3.1 Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Gastrointestinal Cancer Treatment Market Size and Forecast (2017-2028)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Gastrointestinal Cancer Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Gastrointestinal Cancer Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Gastrointestinal Cancer Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Gastrointestinal Cancer Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Gastrointestinal Cancer Treatment Revenue Market Share by Region (2023-2028)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Gastrointestinal Cancer Treatment Product and Solutions
Table 9. Eli Lilly Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. F. Hoffmann Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann Major Business
Table 12. F. Hoffmann Gastrointestinal Cancer Treatment Product and Solutions
Table 13. F. Hoffmann Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Gastrointestinal Cancer Treatment Product and Solutions
Table 17. GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Gastrointestinal Cancer Treatment Product and Solutions
Table 21. Merck Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 23. Novartis AG Major Business
Table 24. Novartis AG Gastrointestinal Cancer Treatment Product and Solutions
Table 25. Novartis AG Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Otsuka Holdings Corporate Information, Head Office, and Major Competitors
Table 27. Otsuka Holdings Major Business
Table 28. Otsuka Holdings Gastrointestinal Cancer Treatment Product and Solutions
Table 29. Otsuka Holdings Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Stryker Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Stryker Corporation Major Business
Table 32. Stryker Corporation Gastrointestinal Cancer Treatment Product and Solutions
Table 33. Stryker Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Boston Scientific Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Boston Scientific Corporation Major Business
Table 36. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product and Solutions
Table 37. Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 39. Johnson and Johnson Major Business
Table 40. Johnson and Johnson Gastrointestinal Cancer Treatment Product and Solutions
Table 41. Johnson and Johnson Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. CONMED Corporation Corporate Information, Head Office, and Major Competitors
Table 43. CONMED Corporation Major Business
Table 44. CONMED Corporation Gastrointestinal Cancer Treatment Product and Solutions
Table 45. CONMED Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 47. Bristol-Myers Squibb Major Business
Table 48. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product and Solutions
Table 49. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Pfizer Corporate Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Gastrointestinal Cancer Treatment Product and Solutions
Table 53. Pfizer Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Celltrion Inc Corporate Information, Head Office, and Major Competitors
Table 55. Celltrion Inc Major Business
Table 56. Celltrion Inc Gastrointestinal Cancer Treatment Product and Solutions
Table 57. Celltrion Inc Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Amgen Limited Corporate Information, Head Office, and Major Competitors
Table 59. Amgen Limited Major Business
Table 60. Amgen Limited Gastrointestinal Cancer Treatment Product and Solutions
Table 61. Amgen Limited Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 63. Celgene Corporation Major Business
Table 64. Celgene Corporation Gastrointestinal Cancer Treatment Product and Solutions
Table 65. Celgene Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Sanofi Corporate Information, Head Office, and Major Competitors
Table 67. Sanofi Major Business
Table 68. Sanofi Gastrointestinal Cancer Treatment Product and Solutions
Table 69. Sanofi Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Gastrointestinal Cancer Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Gastrointestinal Cancer Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Gastrointestinal Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Gastrointestinal Cancer Treatment Players Head Office, Products and Services Provided
Table 74. Gastrointestinal Cancer Treatment Mergers & Acquisitions in the Past Five Years
Table 75. Gastrointestinal Cancer Treatment New Entrants and Expansion Plans
Table 76. Global Gastrointestinal Cancer Treatment Revenue (USD Million) by Type (2017-2022)
Table 77. Global Gastrointestinal Cancer Treatment Revenue Share by Type (2017-2022)
Table 78. Global Gastrointestinal Cancer Treatment Revenue Forecast by Type (2023-2028)
Table 79. Global Gastrointestinal Cancer Treatment Revenue by Application (2017-2022)
Table 80. Global Gastrointestinal Cancer Treatment Revenue Forecast by Application (2023-2028)
Table 81. North America Gastrointestinal Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Gastrointestinal Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Gastrointestinal Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Gastrointestinal Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Gastrointestinal Cancer Treatment Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Gastrointestinal Cancer Treatment Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Gastrointestinal Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Gastrointestinal Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Gastrointestinal Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Gastrointestinal Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Gastrointestinal Cancer Treatment Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Gastrointestinal Cancer Treatment Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Gastrointestinal Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Gastrointestinal Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Gastrointestinal Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Gastrointestinal Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Gastrointestinal Cancer Treatment Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Gastrointestinal Cancer Treatment Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Gastrointestinal Cancer Treatment Picture
Figure 2. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type in 2021
Figure 3. Surgery
Figure 4. Targeted Drugs Therapy
Figure 5. Chemo Therapy
Figure 6. Adjuvant Chemotherapy
Figure 7. Radiation Therapy
Figure 8. Gastrointestinal Cancer Treatment Revenue Market Share by Application in 2021
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Research Centers Picture
Figure 12. Others Picture
Figure 13. Global Gastrointestinal Cancer Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Gastrointestinal Cancer Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Gastrointestinal Cancer Treatment Revenue Market Share by Region (2017-2028)
Figure 16. Global Gastrointestinal Cancer Treatment Revenue Market Share by Region in 2021
Figure 17. North America Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Gastrointestinal Cancer Treatment Market Drivers
Figure 23. Gastrointestinal Cancer Treatment Market Restraints
Figure 24. Gastrointestinal Cancer Treatment Market Trends
Figure 25. Eli Lilly Recent Developments and Future Plans
Figure 26. F. Hoffmann Recent Developments and Future Plans
Figure 27. GlaxoSmithKline Recent Developments and Future Plans
Figure 28. Merck Recent Developments and Future Plans
Figure 29. Novartis AG Recent Developments and Future Plans
Figure 30. Otsuka Holdings Recent Developments and Future Plans
Figure 31. Stryker Corporation Recent Developments and Future Plans
Figure 32. Boston Scientific Corporation Recent Developments and Future Plans
Figure 33. Johnson and Johnson Recent Developments and Future Plans
Figure 34. CONMED Corporation Recent Developments and Future Plans
Figure 35. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 36. Pfizer Recent Developments and Future Plans
Figure 37. Celltrion Inc Recent Developments and Future Plans
Figure 38. Amgen Limited Recent Developments and Future Plans
Figure 39. Celgene Corporation Recent Developments and Future Plans
Figure 40. Sanofi Recent Developments and Future Plans
Figure 41. Global Gastrointestinal Cancer Treatment Revenue Share by Players in 2021
Figure 42. Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 43. Global Top 3 Players Gastrointestinal Cancer Treatment Revenue Market Share in 2021
Figure 44. Global Top 10 Players Gastrointestinal Cancer Treatment Revenue Market Share in 2021
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 46. Global Gastrointestinal Cancer Treatment Revenue Share by Type in 2021
Figure 47. Global Gastrointestinal Cancer Treatment Market Share Forecast by Type (2023-2028)
Figure 48. Global Gastrointestinal Cancer Treatment Revenue Share by Application in 2021
Figure 49. Global Gastrointestinal Cancer Treatment Market Share Forecast by Application (2023-2028)
Figure 50. North America Gastrointestinal Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 51. North America Gastrointestinal Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 52. North America Gastrointestinal Cancer Treatment Revenue Market Share by Country (2017-2028)
Figure 53. United States Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Canada Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Mexico Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Europe Gastrointestinal Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 57. Europe Gastrointestinal Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 58. Europe Gastrointestinal Cancer Treatment Revenue Market Share by Country (2017-2028)
Figure 59. Germany Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. France Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. United Kingdom Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Russia Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Italy Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Asia-Pacific Gastrointestinal Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 65. Asia-Pacific Gastrointestinal Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 66. Asia-Pacific Gastrointestinal Cancer Treatment Revenue Market Share by Region (2017-2028)
Figure 67. China Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Japan Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South Korea Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. India Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Southeast Asia Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Australia Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South America Gastrointestinal Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 74. South America Gastrointestinal Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 75. South America Gastrointestinal Cancer Treatment Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East and Africa Gastrointestinal Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Gastrointestinal Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Gastrointestinal Cancer Treatment Revenue Market Share by Country (2017-2028)
Figure 81. Turkey Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. UAE Gastrointestinal Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Eli Lilly F. Hoffmann GlaxoSmithKline Merck Novartis AG Otsuka Holdings Stryker Corporation Boston Scientific Corporation Johnson and Johnson CONMED Corporation Bristol-Myers Squibb Pfizer Celltrion Inc Amgen Limited Celgene Corporation Sanofi
Related Reports
22 Feb 2021
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
